Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
or

Genedx Holdings Corp (WGS)

Genedx Holdings Corp (WGS)
75.49 +1.13 (+1.52%) 14:11 ET [NASDAQ]
75.48 x 15 75.72 x 18
Realtime by (Cboe BZX)
75.48 x 15 75.72 x 18
Realtime 75.50 +1.14 (+1.53%) 09:29 ET
Quote Overview for Wed, Jan 22nd, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
75.16
Day High
77.76
Open 75.16
Previous Close 74.36 74.36
Volume 489,508 489,508
Avg Vol 770,839 770,839
Stochastic %K 20.94% 20.94%
Weighted Alpha +634.00 +634.00
5-Day Change +4.72 (+6.56%) +4.72 (+6.56%)
52-Week Range 2.85 - 98.87 2.85 - 98.87
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,042,744
  • Shares Outstanding, K 27,471
  • Annual Sales, $ 202,570 K
  • Annual Income, $ -175,770 K
  • EBIT $ -58 M
  • EBITDA $ -24 M
  • 60-Month Beta 2.02
  • Price/Sales 7.35
  • Price/Cash Flow N/A
  • Price/Book 9.33

Options Overview Details

View History
  • Implied Volatility 79.89% ( -0.88%)
  • Historical Volatility 84.36%
  • IV Percentile 8%
  • IV Rank 5.04%
  • IV High 276.62% on 02/16/24
  • IV Low 69.45% on 08/30/24
  • Put/Call Vol Ratio 0.58
  • Today's Volume 1,129
  • Volume Avg (30-Day) 1,331
  • Put/Call OI Ratio 0.35
  • Today's Open Interest 8,012
  • Open Int (30-Day) 6,622

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate 0.20
  • Number of Estimates 1
  • High Estimate 0.20
  • Low Estimate 0.20
  • Prior Year -0.59
  • Growth Rate Est. (year over year) +133.90%

Price Performance

See More
Period Period Low Period High Performance
1-Month
66.81 +14.84%
on 01/16/25
Period Open: 77.40
98.87 -22.40%
on 01/07/25
-0.68 (-0.87%)
since 12/20/24
3-Month
55.30 +38.74%
on 10/23/24
Period Open: 57.79
98.87 -22.40%
on 01/07/25
+18.93 (+32.77%)
since 10/22/24
52-Week
2.85 +2,592.11%
on 01/25/24
Period Open: 3.35
98.87 -22.40%
on 01/07/25
+73.38 (+2,190.30%)
since 01/22/24

Most Recent Stories

More News
Insider Sale: CHIEF FINANCIAL OFFICER of $WGS (WGS) Sells 263 Shares

Kevin Feeley, the CHIEF FINANCIAL OFFICER of $WGS ($WGS), sold 263 shares of the company on 12-02-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 1.1% of...

WGS : 75.56 (+1.61%)
Insider Sale: CHIEF FINANCIAL OFFICER of $WGS (WGS) Sells 2,108 Shares

Kevin Feeley, the CHIEF FINANCIAL OFFICER of $WGS ($WGS), sold 2,108 shares of the company on 11-22-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 8.4% of...

WGS : 75.56 (+1.61%)
Meet the Healthcare Stock That Produced Nvidia-Sized Gains in Less Than a Year

Cautious investors have long known that healthcare spending rises steadily regardless of the direction of the overall economy. It's considered a defensive sector, but it still contains stocks that can...

NVDA : 147.29 (+4.59%)
WGS : 75.56 (+1.61%)
New Strong Buy Stocks for November 4th

Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:Capitol Federal Financial, Inc. CFFN: This holding company for Capitol Federal Savings Bank has seen the Zacks Consensus Estimate...

WGS : 75.56 (+1.61%)
CFFN : 5.63 (-1.57%)
NBBK : 17.60 (-0.79%)
ISBA : 25.7999 (-0.58%)
VLRS : 8.89 (+1.60%)
GeneDx - AI Healthcare Leader

Summary GeneDx Holdings Corp. offers AI-driven genomics-related diagnostic services, focusing on pediatrics, rare diseases, and hereditary cancer screening, with significant recent price appreciation....

WGS : 75.56 (+1.61%)
PacBio and GeneDx Launch Research Collaboration with the University of Washington to Study Long-Read Whole Genome Sequencing for Increased Diagnostic Yield in Neonatal Care

/PRNewswire/ -- PacBio (Nasdaq: PACB), a leading developer of high-quality, highly accurate sequencing solutions and GeneDx (Nasdaq: WGS), a leader in...

PACB : 1.8100 (+6.47%)
WGS : 75.56 (+1.61%)
Why GeneDx Holdings Stock Lagged the Market Today

A financial-engineering move about to be made by the company is an indication of some deep and challenging problems.

WGS : 75.56 (+1.61%)
NDAQ : 80.44 (+0.71%)
Why Shares of GeneDx Dropped Wednesday

The potential of a reverse split concerned investors.

WGS : 75.56 (+1.61%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

GeneDx Holdings Corp. is at the forefront of transforming healthcare through its industry-leading exome and genome testing and interpretation, fueled by rare disease data sets. GeneDx Holdings Corp., formerly known as Sema4 Holdings Corp., is based in STAMFORD, Conn.

See More

Key Turning Points

3rd Resistance Point 82.11
2nd Resistance Point 78.67
1st Resistance Point 76.51
Last Price 75.56
1st Support Level 70.91
2nd Support Level 67.47
3rd Support Level 65.31

See More

52-Week High 98.87
Last Price 75.56
Fibonacci 61.8% 62.19
Fibonacci 50% 50.86
Fibonacci 38.2% 39.53
52-Week Low 2.85

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar